Immatics (IMTXW) Institutional Ownership → Boost your retirement with these AI payouts (From InvestorPlace) (Ad) Free IMTXW Stock Alerts $2.35 -0.10 (-4.08%) (As of 05/17/2024 06:55 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Immatics (NASDAQ:IMTXW)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.53MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$552.82K Get IMTXW Insider Trade Alerts Want to know when executives and insiders are buying or selling Immatics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IMTXW Institutional Buying and Selling by Quarter Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Immatics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2023 683 Capital Management LLC420,000$1.44M0.1%-9.7%0.000% 8/14/2023 Aristeia Capital LLC919,872$3.02M0.1%-11.3%0.000% 7/26/2023 Privium Fund Management B.V.448,043$1.46M0.3%N/A0.000% 2/14/2023 683 Capital Management LLC464,936$1.17M0.1%-7.0%0.000% (Data available from 1/1/2016 forward) IMTXW Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMTXW shares? During the previous two years, the following institutional investors and hedge funds held shares of Immatics shares: Aristeia Capital LLC ($3.02M), and Privium Fund Management B.V. ($1.46M), 683 Capital Management LLC ($1.44M).Learn more on IMTXW's institutional investors. Which institutional investors have been buying Immatics stock? The following institutional investors have purchased Immatics stock in the last 24 months: Privium Fund Management B.V. ($448.04K). How much institutional buying is happening at Immatics? Institutional investors have bought a total of 448,043 shares in the last 24 months. This purchase volume represents approximately $1.53M in transactions. Which Immatics major shareholders have been selling company stock? The following institutional investors have sold Immatics stock in the last 24 months: Aristeia Capital LLC ($116.71K), and 683 Capital Management LLC ($80K). How much institutional selling is happening at Immatics? Institutional investors have sold a total of 196,708 shares in the last 24 months. This volume of shares sold represents approximately $640.83K in transactions. Related Companies: Alpha Tau Medical Major Shareholders Apollomics Major Shareholders BriaCell Therapeutics Major Shareholders Celularity Major Shareholders Fortress Biotech Major Shareholders Humacyte Major Shareholders Jasper Therapeutics Major Shareholders NewAmsterdam Pharma Major Shareholders OmniAb Major Shareholders This page (NASDAQ:IMTXW) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immatics Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
